(VIANEWS) – Lincoln National Corporation (LNC), Nordic American Tankers Limited (NAT), SM Energy Company (SM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Lincoln National Corporation (LNC)
138.3% sales growth and 25.19% return on equity
Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates through four segments: Annuities, Retirement Plan Services, Life Insurance, and Group Protection. The Annuities segment offers variable, fixed, and indexed variable annuities. The Retirement Plan Services segment provides employers with retirement plan products and services primarily in the defined contribution retirement plan marketplace. This segment offers individual and group variable annuities, group fixed annuities, and mutual fund-based programs; and a range of plan services, including plan recordkeeping, compliance testing, participant education, and trust and custodial services. The Life Insurance segment provides life insurance products, including term insurance, such as single and survivorship versions of universal life insurance; variable universal life insurance; indexed universal life insurance products; and critical illness and long-term care riders. The Group Protection segment offers group non-medical insurance products comprising short and long-term disability, statutory disability and paid family medical leave administration and absence management services, term life, dental, vision and accident, and critical illness benefits and services to the employer marketplace through various forms of employee-paid and employer-paid plans. The company distributes its products through consultants, brokers, planners, agents, financial advisors, third-party administrators, and other intermediaries. Lincoln National Corporation was founded in 1905 and is headquartered in Radnor, Pennsylvania.
Earnings Per Share
As for profitability, Lincoln National Corporation has a trailing twelve months EPS of $9.52.
PE Ratio
Lincoln National Corporation has a trailing twelve months price to earnings ratio of 3.25. Meaning, the purchaser of the share is investing $3.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 56.2%, now sitting on 13.59B for the twelve trailing months.
Yearly Top and Bottom Value
Lincoln National Corporation’s stock is valued at $30.90 at 20:22 EST, way below its 52-week high of $36.46 and way above its 52-week low of $20.85.
Moving Average
Lincoln National Corporation’s value is below its 50-day moving average of $31.01 and above its 200-day moving average of $29.56.
2. Nordic American Tankers Limited (NAT)
47.3% sales growth and 11.44% return on equity
Nordic American Tankers Limited, a tanker company, acquires and charters double-hull tankers in Bermuda and internationally. It operates a fleet of 19 Suezmax crude oil tankers. The company was incorporated in 1995 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Nordic American Tankers Limited has a trailing twelve months EPS of $0.29.
PE Ratio
Nordic American Tankers Limited has a trailing twelve months price to earnings ratio of 12.66. Meaning, the purchaser of the share is investing $12.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.44%.
Yearly Top and Bottom Value
Nordic American Tankers Limited’s stock is valued at $3.67 at 20:22 EST, way under its 52-week high of $4.83 and way above its 52-week low of $3.31.
Moving Average
Nordic American Tankers Limited’s worth is higher than its 50-day moving average of $3.63 and below its 200-day moving average of $3.97.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 50% and 75%, respectively.
3. SM Energy Company (SM)
44.8% sales growth and 22.71% return on equity
SM Energy Company, an independent energy company, engages in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids in the state of Texas. It has working interests in oil and gas producing wells in the Midland Basin and South Texas. The company was formerly known as St. Mary Land & Exploration Company and changed its name to SM Energy Company in May 2010. SM Energy Company was founded in 1908 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, SM Energy Company has a trailing twelve months EPS of $6.92.
PE Ratio
SM Energy Company has a trailing twelve months price to earnings ratio of 6.06. Meaning, the purchaser of the share is investing $6.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.71%.
4. Physicians Realty Trust (DOC)
24% sales growth and 3.72% return on equity
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership (the “operating partnership”), directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of September 30, 2020, owned approximately 97.4% of OP Units.
Earnings Per Share
As for profitability, Physicians Realty Trust has a trailing twelve months EPS of $0.48.
PE Ratio
Physicians Realty Trust has a trailing twelve months price to earnings ratio of 47.08. Meaning, the purchaser of the share is investing $47.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.72%.
Yearly Top and Bottom Value
Physicians Realty Trust’s stock is valued at $22.60 at 20:22 EST, below its 52-week high of $23.14 and way higher than its 52-week low of $15.24.
Revenue Growth
Year-on-year quarterly revenue growth grew by 27.5%, now sitting on 2.41B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 50% and a negative 61.5%, respectively.
5. United Therapeutics Corporation (UTHR)
19.1% sales growth and 19.25% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $21.75.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 16.23. Meaning, the purchaser of the share is investing $16.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.25%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 19.3% and 51.6%, respectively.
6. HCI Group (HCI)
16.3% sales growth and 46.25% return on equity
HCI Group, Inc., together with its subsidiaries, engages in the property and casualty insurance, reinsurance, real estate, and information technology businesses in Florida. It provides residential insurance products, such as homeowners, fire, flood, and wind-only insurance to homeowners, condominium owners, and tenants for properties, as well as offers reinsurance programs. The company also owns and operates waterfront properties and retail shopping centers, and an office building, as well as commercial properties for investment purposes. In addition, it designs and develops web-based applications and products for mobile devices, including SAMS, an online policy administration platform; Harmony, a policy administration platform; ClaimColony, an end-to-end claims management platform; and AtlasViewer, a mapping and data visualization platform. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Earnings Per Share
As for profitability, HCI Group has a trailing twelve months EPS of $12.78.
PE Ratio
HCI Group has a trailing twelve months price to earnings ratio of 8.38. Meaning, the purchaser of the share is investing $8.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.25%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 4.3% and a negative 1.6%, respectively.
Previous days news about HCI Group(HCI)
- Wall street analysts see a 28.2% upside in HCI group (hci): can the stock really move this high?. According to Zacks on Tuesday, 1 October, "Shares of HCI Group (HCI Quick QuoteHCI – Free Report) have gained 11.7% over the past four weeks to close the last trading session at $107.06, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. "
- HCI group (hci) increases despite market slip: here's what you need to know. According to Zacks on Tuesday, 1 October, "Any recent changes to analyst estimates for HCI Group should also be noted by investors. ", "The most recent trading session ended with HCI Group (HCI Quick QuoteHCI – Free Report) standing at $107.40, reflecting a +0.32% shift from the previouse trading day’s closing. "
7. Allegheny Technologies Incorporated (ATI)
12.2% sales growth and 28.61% return on equity
Allegheny Technologies Incorporated manufactures and sells specialty materials and components worldwide. The company operates in two segments, High Performance Materials & Components and Advanced Alloys & Solutions. The company produces high performance materials, including titanium and titanium-based alloys; nickel-and cobalt-based alloys and superalloys; zirconium and related alloys, such as hafnium and niobium; powder alloys; and other specialty materials in long product forms of ingots, billets, bars, rods, wires, and shapes and rectangles, as well as seamless tubes, plus precision forgings, castings, components, and machined parts to the aerospace and defense, medical, oil and gas, and electrical energy markets. It also provides stainless steel, nickel-based alloys, specialty alloys, and titanium and titanium-based alloys in various product forms, including plate, sheet, and precision rolled strip products to various markets, such as chemical and hydrocarbon processing,. Allegheny Technologies Incorporated was founded in 1960 and is based in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Allegheny Technologies Incorporated has a trailing twelve months EPS of $2.65.
PE Ratio
Allegheny Technologies Incorporated has a trailing twelve months price to earnings ratio of 25.01. Meaning, the purchaser of the share is investing $25.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.61%.
Yearly Top and Bottom Value
Allegheny Technologies Incorporated’s stock is valued at $66.27 at 20:22 EST, under its 52-week high of $68.92 and way above its 52-week low of $35.03.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.7%, now sitting on 4.23B for the twelve trailing months.
